COMMD4
gene geneOn this page
Also known as FLJ20452
Summary
COMMD4 (COMM domain containing 4, HGNC:26027) is a protein-coding gene on chromosome 15q24.2, encoding COMM domain-containing protein 4 (Q9H0A8). Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex.
Predicted to be involved in signal transduction. Located in cytosol; intracellular membrane-bounded organelle; and plasma membrane.
Source: NCBI Gene 54939 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 52 total — 1 pathogenic
- MANE Select transcript:
NM_017828
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26027 |
| Approved symbol | COMMD4 |
| Name | COMM domain containing 4 |
| Location | 15q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20452 |
| Ensembl gene | ENSG00000140365 |
| Ensembl biotype | protein_coding |
| OMIM | 616701 |
| Entrez | 54939 |
Gene structure
Transcript identifiers
Ensembl transcripts: 46 — 28 protein_coding, 14 retained_intron, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000267935, ENST00000338995, ENST00000480484, ENST00000561662, ENST00000562310, ENST00000562610, ENST00000562789, ENST00000563220, ENST00000564068, ENST00000564587, ENST00000564815, ENST00000565517, ENST00000565834, ENST00000566230, ENST00000566843, ENST00000567023, ENST00000567195, ENST00000567377, ENST00000567399, ENST00000567720, ENST00000567935, ENST00000568034, ENST00000568301, ENST00000568877, ENST00000569245, ENST00000869634, ENST00000869635, ENST00000869636, ENST00000869637, ENST00000869638, ENST00000869639, ENST00000869640, ENST00000869641, ENST00000928185, ENST00000928186, ENST00000928187, ENST00000928188, ENST00000928189, ENST00000928190, ENST00000928191, ENST00000928192, ENST00000928193, ENST00000928194, ENST00000928195, ENST00000944821, ENST00000944822
RefSeq mRNA: 9 — MANE Select: NM_017828
NM_001284377, NM_001284378, NM_001284379, NM_001321844, NM_001321845, NM_001321846, NM_001321847, NM_001321848, NM_017828
CCDS: CCDS10277, CCDS66834, CCDS66835, CCDS73764, CCDS81909
Canonical transcript exons
ENST00000267935 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001424829 | 75336063 | 75336092 |
| ENSE00001842777 | 75339965 | 75340273 |
| ENSE00003463152 | 75339264 | 75339344 |
| ENSE00003533754 | 75338355 | 75338420 |
| ENSE00003552441 | 75339702 | 75339878 |
| ENSE00003574027 | 75338646 | 75338685 |
| ENSE00003585450 | 75338985 | 75339104 |
| ENSE00003619772 | 75338062 | 75338133 |
Expression profiles
Bgee: expression breadth ubiquitous, 280 present calls, max score 97.71.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.0299 / max 69.9234, expressed in 1778 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 147798 | 9.2129 | 1751 |
| 147797 | 1.0864 | 763 |
| 147799 | 0.7307 | 434 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 97.71 | gold quality |
| right testis | UBERON:0004534 | 97.59 | gold quality |
| right adrenal gland | UBERON:0001233 | 97.45 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 97.41 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 97.24 | gold quality |
| left adrenal gland | UBERON:0001234 | 97.13 | gold quality |
| adrenal cortex | UBERON:0001235 | 96.89 | gold quality |
| granulocyte | CL:0000094 | 96.66 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.16 | gold quality |
| metanephros cortex | UBERON:0010533 | 96.13 | gold quality |
| apex of heart | UBERON:0002098 | 95.88 | gold quality |
| adrenal gland | UBERON:0002369 | 95.73 | gold quality |
| stromal cell of endometrium | CL:0002255 | 95.51 | gold quality |
| testis | UBERON:0000473 | 95.47 | gold quality |
| body of stomach | UBERON:0001161 | 95.40 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.11 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.07 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 95.01 | gold quality |
| transverse colon | UBERON:0001157 | 94.70 | gold quality |
| minor salivary gland | UBERON:0001830 | 94.62 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.57 | gold quality |
| right lobe of liver | UBERON:0001114 | 94.54 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 94.51 | gold quality |
| mucosa of stomach | UBERON:0001199 | 94.43 | gold quality |
| endometrium epithelium | UBERON:0004811 | 94.42 | gold quality |
| right uterine tube | UBERON:0001302 | 94.40 | gold quality |
| ectocervix | UBERON:0012249 | 94.38 | gold quality |
| lower esophagus | UBERON:0013473 | 94.36 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 94.36 | gold quality |
| left coronary artery | UBERON:0001626 | 94.34 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-11121 | yes | 289.70 |
| E-ANND-3 | yes | 8.08 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting COMMD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-513C-5P | 99.50 | 68.42 | 1730 |
| HSA-MIR-514B-5P | 99.50 | 68.19 | 1766 |
| HSA-MIR-4316 | 99.37 | 65.75 | 1360 |
| HSA-MIR-3074-5P | 98.82 | 66.56 | 1414 |
| HSA-MIR-2278 | 97.30 | 66.19 | 1130 |
Literature-anchored findings (GeneRIF, showing 2)
- Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer. (PMID:32439936)
- COMMD4 functions with the histone H2A-H2B dimer for the timely repair of DNA double-strand breaks. (PMID:33875784)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | commd4 | ENSDARG00000061946 |
| mus_musculus | Commd4 | ENSMUSG00000032299 |
| rattus_norvegicus | Commd4 | ENSRNOG00000018671 |
| drosophila_melanogaster | CG34039 | FBGN0054039 |
| caenorhabditis_elegans | T28F2.2 | WBGENE00020901 |
Protein
Protein identifiers
COMM domain-containing protein 4 — Q9H0A8 (reviewed: Q9H0A8)
All UniProt accessions (7): Q9H0A8, A0A0B4J287, H3BM91, H3BPG2, H3BQF2, H3BRX0, H3BTV9
UniProt curated annotations — full annotation on UniProt →
Function. Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex. May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes. Down-regulates activation of NF-kappa-B.
Subunit / interactions. Component of the commander complex consisting of the CCC subcomplex and the retriever subcomplex. Component of the CCC (COMMD/CCDC22/CCDC93) subcomplex consisting of COMMD1, COMMD2, COMMD3, COMMD4, COMMD5, COMMD6, COMMD7, COMMD8, COMMD9, COMMD10, CCDC22 and CCDC93; within the complex forms a heterodimer with COMMD8. Interacts with RELA, RELB, NFKB1/p105. Interacts with CCDC22, CCDC93, SCNN1B, CUL2, CUL3, CUL4A, CUL5, CUL7.
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Ubiquitous.
Similarity. Belongs to the COMM domain-containing protein 4 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H0A8-1 | 1 | yes |
| Q9H0A8-2 | 2 | |
| Q9H0A8-3 | 3 |
RefSeq proteins (9): NP_001271306, NP_001271307, NP_001271308, NP_001308773, NP_001308774, NP_001308775, NP_001308776, NP_001308777, NP_060298* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR017920 | COMM | Domain |
| IPR037356 | COMMD4 | Family |
| IPR047155 | COMMD4/6/7/8 | Family |
Pfam: PF07258, PF21672
UniProt features (16 total): helix 8, strand 3, splice variant 2, chain 1, domain 1, turn 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9ZMZ | X-RAY DIFFRACTION | 2.12 |
| 8P0W | ELECTRON MICROSCOPY | 2.9 |
| 8F2R | ELECTRON MICROSCOPY | 3.12 |
| 8F2U | ELECTRON MICROSCOPY | 3.53 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H0A8-F1 | 80.85 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8951664 | Neddylation |
MSigDB gene sets: 141 (showing top):
MULLIGHAN_NPM1_SIGNATURE_3_UP, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ENDOCYTIC_RECYCLING, BASAKI_YBX1_TARGETS_UP, GOBP_LOCALIZATION_WITHIN_MEMBRANE, NUYTTEN_EZH2_TARGETS_DN, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, GOCC_MEMBRANE_PROTEIN_COMPLEX, MORF_RAN, MULLIGHAN_MLL_SIGNATURE_1_UP, MORF_CSNK2B, MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP, MORF_PSMC1, MORF_G22P1, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
GO Biological Process (1): signal transduction (GO:0007165)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): nucleus (GO:0005634), cytoplasm (GO:0005737), cytosol (GO:0005829), plasma membrane (GO:0005886)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
1779 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COMMD4 | COMMD2 | Q86X83 | 832 |
| COMMD4 | CCDC22 | O60826 | 775 |
| COMMD4 | COMMD3 | Q9UBI1 | 775 |
| COMMD4 | COMMD9 | Q9P000 | 760 |
| COMMD4 | COMMD1 | Q8N668 | 671 |
| COMMD4 | VPS26C | O14972 | 634 |
| COMMD4 | COMMD5 | Q9GZQ3 | 627 |
| COMMD4 | COMMD8 | Q9NX08 | 621 |
| COMMD4 | COMMD6 | Q7Z4G1 | 614 |
| COMMD4 | COMMD10 | Q9Y6G5 | 571 |
| COMMD4 | DPM3 | Q9P2X0 | 514 |
| COMMD4 | A0A2R8Y455 | A0A2R8Y455 | 507 |
| COMMD4 | COMMD7 | Q86VX2 | 506 |
| COMMD4 | ACYP1 | P07311 | 476 |
| COMMD4 | R4GMX3 | R4GMX3 | 471 |
IntAct
109 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COMMD1 | CCDC22 | psi-mi:“MI:0914”(association) | 0.970 |
| CCDC22 | CCDC93 | psi-mi:“MI:0915”(physical association) | 0.960 |
| CCDC22 | CCDC93 | psi-mi:“MI:0914”(association) | 0.960 |
| COMMD1 | COMMD6 | psi-mi:“MI:0914”(association) | 0.950 |
| COMMD1 | COMMD6 | psi-mi:“MI:0915”(physical association) | 0.950 |
| CCDC22 | COMMD6 | psi-mi:“MI:0914”(association) | 0.930 |
| COMMD2 | CCDC22 | psi-mi:“MI:0914”(association) | 0.930 |
| CCDC22 | COMMD4 | psi-mi:“MI:0915”(physical association) | 0.920 |
| COMMD1 | COMMD4 | psi-mi:“MI:0915”(physical association) | 0.920 |
| COMMD4 | COMMD8 | psi-mi:“MI:0915”(physical association) | 0.880 |
| COMMD4 | COMMD8 | psi-mi:“MI:0914”(association) | 0.880 |
| ODAD1 | HGS | psi-mi:“MI:0914”(association) | 0.850 |
| COMMD2 | COMMD4 | psi-mi:“MI:0915”(physical association) | 0.820 |
| COMMD4 | CCDC93 | psi-mi:“MI:0915”(physical association) | 0.800 |
| CCDC22 | VPS26C | psi-mi:“MI:0914”(association) | 0.790 |
| VPS29 | VPS26C | psi-mi:“MI:0914”(association) | 0.760 |
| COMMD1 | VPS26C | psi-mi:“MI:0914”(association) | 0.730 |
| COMMD4 | VPS26C | psi-mi:“MI:0914”(association) | 0.730 |
| E2F6 | WDR5 | psi-mi:“MI:0914”(association) | 0.730 |
BioGRID (195): COMMD4 (Affinity Capture-MS), COMMD4 (Affinity Capture-MS), COMMD4 (Affinity Capture-MS), COMMD4 (Affinity Capture-MS), COMMD4 (Affinity Capture-MS), COMMD2 (Affinity Capture-MS), C16orf62 (Affinity Capture-MS), CCDC93 (Affinity Capture-MS), COMMD10 (Affinity Capture-MS), TP53RK (Affinity Capture-MS), EXOSC4 (Affinity Capture-MS), COMMD7 (Affinity Capture-MS), FAM45A (Affinity Capture-MS), EXOSC2 (Affinity Capture-MS), COMMD6 (Affinity Capture-MS)
ESM2 similar proteins: A4IFQ0, A4QNE0, O09172, O75031, P41214, P48507, P48508, P48553, P50747, P54198, Q08BT5, Q0P5I8, Q13769, Q2T9Y6, Q2TBN5, Q3B7L5, Q3T0J1, Q3TLI0, Q5E9V6, Q5R812, Q5RA63, Q5RAQ5, Q61666, Q66H91, Q68FF6, Q68FX7, Q6DFV5, Q6NRL4, Q6P6Y1, Q6ZPY2, Q76JQ2, Q7L5D6, Q8BKT7, Q8JZY2, Q8K2Q0, Q8R1T1, Q8WUX9, Q91W86, Q91W96, Q920N2
Diamond homologs: Q550I8, Q5E9V6, Q9CQ02, Q9H0A8
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 64 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Neddylation | 11 | 13.0× | 1e-07 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| endocytic recycling | 6 | 28.2× | 3e-05 |
| cilium assembly | 8 | 10.3× | 2e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 58080 | GRCh38/hg38 15q24.2(chr15:75336215-75658670)x3 | Pathogenic |
SpliceAI
1446 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:75338061:GA:G | acceptor_gain | 1.0000 |
| 15:75338133:GGT:G | donor_gain | 1.0000 |
| 15:75338135:T:G | donor_gain | 1.0000 |
| 15:75338135:T:TG | donor_gain | 1.0000 |
| 15:75338139:G:GG | donor_gain | 1.0000 |
| 15:75338353:A:AG | acceptor_gain | 1.0000 |
| 15:75338354:G:GG | acceptor_gain | 1.0000 |
| 15:75338644:A:AG | acceptor_gain | 1.0000 |
| 15:75338645:G:GG | acceptor_gain | 1.0000 |
| 15:75338645:GT:G | acceptor_gain | 1.0000 |
| 15:75338684:TGG:T | donor_loss | 1.0000 |
| 15:75338685:GGT:G | donor_loss | 1.0000 |
| 15:75338686:GT:G | donor_loss | 1.0000 |
| 15:75338973:C:CA | acceptor_gain | 1.0000 |
| 15:75339341:CGCA:C | donor_gain | 1.0000 |
| 15:75339342:GCA:G | donor_gain | 1.0000 |
| 15:75339342:GCAG:G | donor_gain | 1.0000 |
| 15:75339343:CA:C | donor_gain | 1.0000 |
| 15:75339343:CAG:C | donor_loss | 1.0000 |
| 15:75339344:AGT:A | donor_loss | 1.0000 |
| 15:75339345:G:GG | donor_gain | 1.0000 |
| 15:75339346:TAA:T | donor_loss | 1.0000 |
| 15:75339700:A:AG | acceptor_gain | 1.0000 |
| 15:75339701:G:GG | acceptor_gain | 1.0000 |
| 15:75339701:GTGA:G | acceptor_gain | 1.0000 |
| 15:75336093:G:GG | donor_gain | 0.9900 |
| 15:75336094:T:G | donor_loss | 0.9900 |
| 15:75336098:GCAC:G | donor_gain | 0.9900 |
| 15:75338057:TGCA:T | acceptor_loss | 0.9900 |
| 15:75338058:GCA:G | acceptor_loss | 0.9900 |
AlphaMissense
1283 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:75338065:T:C | F3L | 0.999 |
| 15:75338067:C:A | F3L | 0.999 |
| 15:75338067:C:G | F3L | 0.999 |
| 15:75338098:T:A | W14R | 0.999 |
| 15:75338098:T:C | W14R | 0.999 |
| 15:75338100:G:C | W14C | 0.999 |
| 15:75338100:G:T | W14C | 0.999 |
| 15:75339081:T:C | L93P | 0.997 |
| 15:75338066:T:C | F3S | 0.996 |
| 15:75338066:T:G | F3C | 0.996 |
| 15:75339096:T:C | L98P | 0.996 |
| 15:75338071:T:C | F5L | 0.995 |
| 15:75338073:C:A | F5L | 0.995 |
| 15:75338073:C:G | F5L | 0.995 |
| 15:75338091:T:G | C11W | 0.995 |
| 15:75339093:G:A | G97E | 0.995 |
| 15:75338089:T:C | C11R | 0.994 |
| 15:75339968:T:C | L188P | 0.994 |
| 15:75338065:T:G | F3V | 0.993 |
| 15:75338078:G:T | G7V | 0.993 |
| 15:75338090:G:A | C11Y | 0.993 |
| 15:75338105:T:C | L16P | 0.993 |
| 15:75339090:T:C | L96P | 0.993 |
| 15:75338099:G:T | W14L | 0.992 |
| 15:75339039:C:A | A79E | 0.992 |
| 15:75339078:A:T | E92V | 0.992 |
| 15:75339092:G:A | G97R | 0.992 |
| 15:75339092:G:C | G97R | 0.992 |
| 15:75338065:T:A | F3I | 0.991 |
| 15:75338099:G:C | W14S | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000233675 (15:75334743 A>C), RS1000302644 (15:75339554 C>A,G,T), RS1000694685 (15:75338291 G>C), RS1000771377 (15:75343652 T>G), RS1000890935 (15:75338466 A>C,G), RS1000967784 (15:75342917 C>G), RS1001854713 (15:75342887 T>C,G), RS1002030519 (15:75341401 G>A,T), RS1003627901 (15:75335163 A>G), RS1004184441 (15:75339786 A>C), RS1004590468 (15:75341042 G>C), RS1004644507 (15:75340831 G>A), RS1004820075 (15:75336346 G>C), RS1005089694 (15:75336518 C>A,T), RS1005334432 (15:75342631 C>T)
Disease associations
OMIM: gene MIM:616701 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007725_8 | Serum uric acid levels | 1.000000e-08 |
| GCST008790_51 | Urinary albumin-to-creatinine ratio | 4.000000e-16 |
| GCST008791_10 | Microalbuminuria | 2.000000e-07 |
| GCST008971_14 | Urate levels | 2.000000e-07 |
| GCST008972_197 | Urate levels | 3.000000e-12 |
| GCST008972_43 | Urate levels | 3.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004761 | uric acid measurement |
| EFO:0007778 | urinary albumin to creatinine ratio |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
40 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression, increases abundance | 2 |
| cobaltous chloride | decreases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| 2,4,6-tribromophenol | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| lasiocarpine | increases expression | 1 |
| bisphenol A | affects expression | 1 |
| decabromobiphenyl ether | decreases expression | 1 |
| beta-lapachone | increases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| cypermethrin | increases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| cupric chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| chromium hexavalent ion | decreases expression, increases abundance | 1 |
| K 7174 | decreases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| hexabrominated diphenyl ether 153 | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Cisplatin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.